Cargando…

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently highly debated therapeutic implications. Several trials on vitamin D supplementation in HF showed improvements in left ventricular (LV) remodeling and function and health-related quality of life (HRQoL), whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabo, Timea Magdolna, Nagy, Előd Ernő, Kirchmaier, Ádám, Heidenhoffer, Erhard, Gábor-Kelemen, Hunor-László, Frăsineanu, Marius, Cseke, Judit, Germán-Salló, Márta, Frigy, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669750/
https://www.ncbi.nlm.nih.gov/pubmed/38002259
http://dx.doi.org/10.3390/biom13111578
_version_ 1785139768873451520
author Szabo, Timea Magdolna
Nagy, Előd Ernő
Kirchmaier, Ádám
Heidenhoffer, Erhard
Gábor-Kelemen, Hunor-László
Frăsineanu, Marius
Cseke, Judit
Germán-Salló, Márta
Frigy, Attila
author_facet Szabo, Timea Magdolna
Nagy, Előd Ernő
Kirchmaier, Ádám
Heidenhoffer, Erhard
Gábor-Kelemen, Hunor-László
Frăsineanu, Marius
Cseke, Judit
Germán-Salló, Márta
Frigy, Attila
author_sort Szabo, Timea Magdolna
collection PubMed
description Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently highly debated therapeutic implications. Several trials on vitamin D supplementation in HF showed improvements in left ventricular (LV) remodeling and function and health-related quality of life (HRQoL), which did not translate into mid- to long-term beneficial effects regarding physical performance and mortality. We addressed total 25-hydroxyvitamin D (25(OH)D), serum albumin, and uric acid (UA) levels, focusing mainly on vitamin D deficiency, as potential markers of LV systolic dysfunction in HF with reduced and mildly reduced ejection fraction (HFrEF, HFmrEF). Seventy patients with LVEF < 50% were comprehensively evaluated using ECG, echocardiography, lung ultrasound (LUS), blood sampling, and the six-minute walk test (6MWT). HRQoL was also assessed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Statistically significant positive correlations were found between LVEF, 25(OH)D, serum UA, and albumin, respectively (p = 0.008, p = 0.009, and p = 0.001). Serum UA (7.4 ± 2.4 vs. 5.7 ± 2.1, p = 0.005), NT-proBNP levels (1090.4 (675.2–2664.9) vs. 759.0 (260.3–1474.8), p = 0.034), and MLHFQ scores (21.0 (14.0–47.0) vs. 14.5 (4.5–25.5), p = 0.012) were significantly higher, whereas 25(OH)D concentrations (17.6 (15.1–28.2) vs. 22.7 (19.5–33.8), p = 0.010) were lower in subjects with severely reduced LVEF. Also, 25(OH)D was independently associated with LVEF in univariate and multiple regression analysis, maintaining its significance even after adjusting for confounders such as age, NT-proBNP, the presence of chronic coronary syndrome, hypertension, and anemia. According to our current findings, 25(OH)D is closely associated with LVEF, further supporting the need to establish correct vitamin D supplementation schemes and dietary interventions in HF. The changes in LVEF, 25(OH)D, serum UA, and albumin levels in HFrEF and HFmrEF indicate a similar pathophysiological background.
format Online
Article
Text
id pubmed-10669750
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106697502023-10-26 Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction Szabo, Timea Magdolna Nagy, Előd Ernő Kirchmaier, Ádám Heidenhoffer, Erhard Gábor-Kelemen, Hunor-László Frăsineanu, Marius Cseke, Judit Germán-Salló, Márta Frigy, Attila Biomolecules Article Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently highly debated therapeutic implications. Several trials on vitamin D supplementation in HF showed improvements in left ventricular (LV) remodeling and function and health-related quality of life (HRQoL), which did not translate into mid- to long-term beneficial effects regarding physical performance and mortality. We addressed total 25-hydroxyvitamin D (25(OH)D), serum albumin, and uric acid (UA) levels, focusing mainly on vitamin D deficiency, as potential markers of LV systolic dysfunction in HF with reduced and mildly reduced ejection fraction (HFrEF, HFmrEF). Seventy patients with LVEF < 50% were comprehensively evaluated using ECG, echocardiography, lung ultrasound (LUS), blood sampling, and the six-minute walk test (6MWT). HRQoL was also assessed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Statistically significant positive correlations were found between LVEF, 25(OH)D, serum UA, and albumin, respectively (p = 0.008, p = 0.009, and p = 0.001). Serum UA (7.4 ± 2.4 vs. 5.7 ± 2.1, p = 0.005), NT-proBNP levels (1090.4 (675.2–2664.9) vs. 759.0 (260.3–1474.8), p = 0.034), and MLHFQ scores (21.0 (14.0–47.0) vs. 14.5 (4.5–25.5), p = 0.012) were significantly higher, whereas 25(OH)D concentrations (17.6 (15.1–28.2) vs. 22.7 (19.5–33.8), p = 0.010) were lower in subjects with severely reduced LVEF. Also, 25(OH)D was independently associated with LVEF in univariate and multiple regression analysis, maintaining its significance even after adjusting for confounders such as age, NT-proBNP, the presence of chronic coronary syndrome, hypertension, and anemia. According to our current findings, 25(OH)D is closely associated with LVEF, further supporting the need to establish correct vitamin D supplementation schemes and dietary interventions in HF. The changes in LVEF, 25(OH)D, serum UA, and albumin levels in HFrEF and HFmrEF indicate a similar pathophysiological background. MDPI 2023-10-26 /pmc/articles/PMC10669750/ /pubmed/38002259 http://dx.doi.org/10.3390/biom13111578 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Szabo, Timea Magdolna
Nagy, Előd Ernő
Kirchmaier, Ádám
Heidenhoffer, Erhard
Gábor-Kelemen, Hunor-László
Frăsineanu, Marius
Cseke, Judit
Germán-Salló, Márta
Frigy, Attila
Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title_full Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title_fullStr Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title_full_unstemmed Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title_short Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
title_sort total 25-hydroxyvitamin d is an independent marker of left ventricular ejection fraction in heart failure with reduced and mildly reduced ejection fraction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669750/
https://www.ncbi.nlm.nih.gov/pubmed/38002259
http://dx.doi.org/10.3390/biom13111578
work_keys_str_mv AT szabotimeamagdolna total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT nagyeloderno total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT kirchmaieradam total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT heidenhoffererhard total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT gaborkelemenhunorlaszlo total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT frasineanumarius total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT csekejudit total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT germansallomarta total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction
AT frigyattila total25hydroxyvitamindisanindependentmarkerofleftventricularejectionfractioninheartfailurewithreducedandmildlyreducedejectionfraction